Compugen (CGEN) Tax Provisions (2013 - 2026)
Compugen (CGEN) reported Tax Provisions of $5000.0 for Q1 2026, down 83.87% on a YoY basis from $31000.0 in Q1 2025, and down 95.37% sequentially from $108000.0 in Q4 2025.
Compugen (CGEN) Tax Provisions (2013 - 2026) Analysis & Trends
Compugen (CGEN) has 9 years of Tax Provisions data on file, last reported at $5000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 83.87% year-over-year to $5000.0; the trailing twelve-month figure through Mar 2026 stood at $28000.0 (up 100.62% YoY), and the FY2025 full-year result was $54000.0, down 98.81% from the prior year.
- Tax Provisions eased to $5000.0 in Q1 2026, from $108000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $9.0 million in Q4 2023 to a low of -$4.5 million in Q3 2024.
- A 5-year average of $357307.7 and a median of $5000.0 in 2026 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions jumped 15427.59% in 2023 and plunged 173.91% in 2024, its largest moves.
- Tracing CGEN's Tax Provisions over 5 years: stood at $58000.0 in 2022, then jumped by 15427.59% to $9.0 million in 2023, then plunged by 99.96% to $4000.0 in 2024, then surged by 2600.0% to $108000.0 in 2025, then slumped by 95.37% to $5000.0 in 2026.
- Business Quant data shows CGEN's Tax Provisions at $5000.0 in Q1 2026, $108000.0 in Q4 2025, and -$40000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | -40,000.00 |
| Jun 30, 2025 | -45,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | -4.50 Mn |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 9.01 Mn |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2021 | 2.02 Mn |
| Dec 31, 2015 | 390,000.00 |
| Dec 31, 2014 | 300,000.00 |
| Jun 30, 2014 | -60,000.00 |
| Dec 31, 2013 | 345,000.00 |
| Sep 30, 2013 | 155,000.00 |